Sangamo Therapeutics
SGMO
SGMO
184 hedge funds and large institutions have $744M invested in Sangamo Therapeutics in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
4% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 25
14% less capital invested
Capital invested by funds: $860M → $744M (-$116M)
Holders
184
Holding in Top 10
–
Calls
$14.9M
Puts
$12.1M
Top Buyers
| 1 | +$9.34M | |
| 2 | +$4.97M | |
| 3 | +$4.67M | |
| 4 |
Morgan Stanley
New York
|
+$3.39M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$2.71M |
Top Sellers
| 1 | -$5.06M | |
| 2 | -$5.01M | |
| 3 | -$3.03M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.98M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.13M |